Predictive Accuracy of Surrogate Indices for Hepatic and Skeletal Muscle Insulin Sensitivity
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
Surrogate indices of muscle and hepatic insulin sensitivity derived from an oral glucose tolerance test (OGTT) are frequently used in clinical studies. However, the predictive accuracy of these indices has not been validated. In this cross-sectional study, hyperinsulinemic-euglycemic glucose clamp with tritiated glucose infusion and a 75-g OGTT were performed in individuals (n = 659, aged 18 to 49 years, body mass index of 16 to 64 kg/m2) with varying degrees of glucose tolerance. A calibration model was used to assess the ability of OGTT-derived, tissue-specific surrogate indices [hepatic insulin resistance index (HIRI) and muscle insulin sensitivity index (MISI)] to predict insulin sensitivity/resistance indices derived from the reference glucose clamp [Hepatic-IRbasal, a product of fasting plasma insulin and hepatic glucose production (HGP), Hepatic-IRclamp, reciprocal of the percent suppression of HGP during the insulin clamp corrected for plasma insulin concentration, and Muscle-ISclamp, a measure of peripheral glucose disposal]. Predictive accuracy was assessed by root mean squared error of prediction and leave-one-out, cross-validation-type square root of the mean squared error of prediction. HIRI and MISI were correlated with their respective clamp-derived indices. HIRI was negatively related to Muscle-ISclamp (r = –0.62, P < 0.0001) and MISI correlated with Hepatic-IR derived from the clamp (Hepatic-IRbasal: r = –0.48, P < 0.0001 and Hepatic-IRclamp: r = –0.41, P < 0.0001). However, the accuracy of HIRI and MISI to predict Hepatic-IR (basal or during clamp) was not significantly different. Likewise, the ability of HIRI and MISI to predict Muscle-ISclamp was also similar. Our findings indicate that the surrogate indices derived from an OGTT are accurate in predicting insulin sensitivity but are not tissue specific.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We and others have previously shown that HIRI predicts and correlates well with hepatic insulin resistance as measured with the reference glucose clamp technique (r=0.49) [32].”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [32]
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 2×
“, metformin and thiazolidinediones) also improve insulin action and reduce the risk of conversion from impaired glucose tolerance (IGT) to type 2 diabetes [11].”
BackgroundTuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“The “hyperinsulinemic euglycemic glucose clamp” is widely accepted as the reference method to evaluate insulin sensitivity because it can directly measure insulin-mediated suppression of HGP and whole-body glucose disposal [16].”
MethodMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 2×
“Therefore, to quantitate insulin sensitivity, several simpler methods were derived from the OGTT [35], a commonly used test to assess glucose homeostasis in clinical practice, epidemiological studies, and research settings.”
BackgroundMethodDeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535 · cited 2×
“Insulin resistance, a characteristic feature of type 2 diabetes [33] [34], is associated with obesity and atherosclerotic cardiovascular disease [4].”
BackgroundKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 1×
“7), where M is the glucose infusion rate (mg/min) and I is the steady-state plasma insulin concentrations (mU/mL)] [27].”
BackgroundFollow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102 · cited 1×
“Skeletal muscle insulin resistance is characterized by reduced insulinmediated glucose disposal and contributes to postprandial hyperglycemia [7].”
BackgroundMuniyappa, R., Lee, S., Chen, H., & Quon, M. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00645.2007 · Cited by 1,643 · cited 3×
“As impaired insulin action is the cornerstone for the development of type 2 diabetes and metabolic syndrome, there has been widespread interest in the development of techniques and methods to assess insulin sensitivity [2].”
BackgroundMethodInfluentialSelf-citationTechniques for Measuring Body Composition
(1961) · National Academies Press eBooks · doi:10.17226/21603 · Cited by 1,611
Mazess, R., Barden, H., Bisek, J., & Hanson, J. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.6.1106 · Cited by 1,476 · cited 1×
“This subset included individuals in their first visit who had complete data onOGTT, insulin actionmeasured by the gold-standard glucose clamp technique, and body composition measured by either underwater weighing with simultaneous determination of residual lung volume by helium dilution [22] or dual energy x-ray absor…”
MethodInsulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,358 · cited 1×
“Skeletal muscle and hepatic insulin resistance play a major pathophysiological role in type 2 diabetes and is frequently observed in obesity, hypertension, dyslipidemia, coronary heart disease, and the metabolic syndrome [4, 5].”
BackgroundAssessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.
Stumvoll, M., Mitrakou, A., Pimenta, W., Jenssen, T., Yki-Järvinen, H., Van Haeften, T., Renn, W., & Gerich, J. (2000) · Diabetes Care · doi:10.2337/diacare.23.3.295 · Cited by 1,042 · cited 1×
“After an oral glucose challenge, the HGP is maximally suppressed reaching a nadir at approximately 60 minutes and remains suppressed for the duration (~180minutes) [17, 18].”
BackgroundPetersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
Self-citationGroop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812
Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus
Inzucchi, S. E., Maggs, D. G., Spollett, G. R., Page, S. L., Rife, F. S., Walton, V., & Shulman, G. I. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381303 · Cited by 794
Abdul-Ghani, M. A., Tripathy, D., & DeFronzo, R. A. (2006) · Diabetes Care · doi:10.2337/dc05-2179 · Cited by 744
Impaired Glucose Tolerance as a Disorder of Insulin Action
Lillioja, S., Mott, D. M., Howard, B. V., Bennett, P. H., Yki-Järvinen, H., Freymond, D., Nyomba, B. L., Zurlo, F., Swinburn, B., & Bogardus, C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181901 · Cited by 578 · cited 2×
“A total of 659 volunteers participating in a longitudinal study of predictors of type 2 diabetes were included in this study [20, 21].”
BackgroundMethodMuscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance Test
Abdul-Ghani, M. A., Matsuda, M., Balas, B., & DeFronzo, R. A. (2007) · Diabetes Care · doi:10.2337/dc06-1519 · Cited by 555
Cusi, K. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.4059 · Cited by 455
The Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative Study
Ferrannini, E., Bjorkman, O., Reichard, G. A., Pilo, A., Olsson, M., Wahren, J., & DeFronzo, R. A. (1985) · Diabetes · doi:10.2337/diab.34.6.580 · Cited by 439 · cited 1×
“After an oral glucose challenge, the HGP is maximally suppressed reaching a nadir at approximately 60 minutes and remains suppressed for the duration (~180minutes) [17, 18].”
BackgroundIdentification of Individuals With Insulin Resistance Using Routine Clinical Measurements
Stern, S. E., Williams, K., Ferrannini, E., DeFronzo, R. A., Bogardus, C., & Stern, M. P. (2005) · Diabetes · doi:10.2337/diabetes.54.2.333 · Cited by 384
Mooy, J. M., Grootenhuis, P. A., de Vries, H., Kostense, P. J., Popp-Snijders, C., Bouter, L. M., & Heine, R. J. (1996) · Diabetologia · doi:10.1007/bf00418345 · Cited by 344 · cited 1×
“OGTT-derived indices generally have high within-subject variability [43].”
BackgroundMeyer, C., Pimenta, W., Woerle, H. J., Van Haeften, T., Szoke, E., Mitrakou, A., & Gerich, J. (2006) · Diabetes Care · doi:10.2337/dc06-0438 · Cited by 308 · cited 1×
“In fact, hepatic and muscle insulin resistance differentially affect the development of impaired fasting glucose and postprandial glucose intolerance [9, 10].”
BackgroundChen, H., Sullivan, G., & Quon, M. J. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1914 · Cited by 270
In Vivo Insulin Action Is Familial Characteristic in Nondiabetic Pima Indians
Lillioja, S., Mott, D. M., Zawadzki, J. K., Young, A. A., Abbott, W. G. H., Knowler, W. C., Bennett, P. H., Moll, P., & Bogardus, C. (1987) · Diabetes · doi:10.2337/diab.36.11.1329 · Cited by 269 · cited 1×
“A significant portion of the study cohort (~78%) are American Indians who are well known to be insulin resistant [30].”
BackgroundUse of dual-energy X-ray absorptiometry in obese individuals
Tataranni, P., & Ravussin, E. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.4.730 · Cited by 250 · cited 1×
“The absorptiometry measures were converged to comparable underwater weighing values, using previously derived equations to calculate body fat percentage [24].”
MethodRole of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man.
Groop, L. C., Bonadonna, R. C., Shank, M., Petrides, A. S., & DeFronzo, R. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115005 · Cited by 181 · cited 1×
“Insulin resistance, a characteristic feature of type 2 diabetes [33] [34], is associated with obesity and atherosclerotic cardiovascular disease [4].”
BackgroundJeng, C.-Y., Sheu, W. H.-H., Fuh, M. M.-T., Chen, Y.-D. I., & Reaven, G. M. (1994) · Diabetes · doi:10.2337/diab.43.12.1440 · Cited by 118
Blanco-Rojo, R., Alcala-Diaz, J. F., Wopereis, S., Pérez‐Martínez, P., Quintana‐Navarro, G. M., Marín, C., Ordovás, J. M., van Ommen, B., Pérez‐Jiménez, F., Delgado‐Lista, J., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3776-4 · Cited by 112
Wlazlo, N., van Greevenbroek, M. M. J., Ferreira, I., Feskens, E. J. M., van der Kallen, C. J. H., Schalkwijk, C. G., Bravenboer, B., & Stehouwer, C. D. A. (2014) · Diabetes Care · doi:10.2337/dc13-2804 · Cited by 96
Haufe, S., Haas, V., Utz, W., Birkenfeld, A. L., Jeran, S., Böhnke, J., Mähler, A., Luft, F. C., Schulz-Menger, J., Boschmann, M., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0102 · Cited by 72
A novel surrogate index for hepatic insulin resistance
the EGIR-RISC Study Group, Vangipurapu, J., Stančáková, A., Kuulasmaa, T., Paananen, J., Kuusisto, J., Ferrannini, E., & Laakso, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1966-7 · Cited by 60
How to measure hepatic insulin resistance?
Choukem, S. P., & Gautier, J. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74602-0 · Cited by 55
Strong association between insulin resistance in liver and skeletal muscle in non‐diabetic subjects
Abdul‐Ghani, M. A., Matsuda, M., & DeFronzo, R. A. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02597.x · Cited by 48 · cited 1×
“Furthermore, insulin resistance in liver and muscle are strongly associated [1].”
BackgroundMuscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance Test
Bastard, J.-P., Faraj, M., Karelis, A. D., Lavasseur, J., Garrel, D., Prud'homme, D., & Rabasa-Lhoret, R. (2007) · Diabetes Care · doi:10.2337/dc07-0622 · Cited by 41
Leon‐Acuña, A., Alcala-Diaz, J. F., Delgado‐Lista, J., Torres-Peña, J. D., López-Moreno, J., Camargo, A., García‐Ríos, A., Marín, C., Gómez-Delgado, F., Caballero‐Villarraso, J., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0380-y · Cited by 41
FízeI'ová, M., Cederberg, H., Stančáková, A., Jauhiainen, R., Vangipurapu, J., Kuusisto, J., & Laakso, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109772 · Cited by 18
Muniyappa, R., Irving, B. A., Unni, U. S., Briggs, W. M., Nair, K. S., Quon, M. J., & Kurpad, A. V. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00454.2010 · Cited by 17 · cited 1×
“insulin sensitivity measures derived from a clamp [28, 29].”
BackgroundSelf-citationAssessment of non–insulin-mediated glucose uptake: association with body fat and glycemic status
von Schwartzenberg, R. J., Thearle, M. S., Bunt, J. C., & Krakoff, J. A. (2010) · Metabolism · doi:10.1016/j.metabol.2010.01.006 · Cited by 13
Self-citation
Cited by
Vogelzangs, N., Kallen, C., van Greevenbroek, M. M. J., van der Kolk, B. W., Jocken, J. W. E., Goossens, G. H., Schaper, N. C., Henry, R. M. A., Eussen, S. J. P. M., Valsesia, A., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0565-z · Cited by 76
Debray, F., Seyssel, K., Fadeur, M., Tappy, L., Paquot, N., & Tran, C. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.01.026 · Cited by 27
Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism
Grewal, S., Fosam, A., Chalk, L., Deven, A., Suzuki, M., Correa, R. R., Blau, J. E., Demidowich, A. P., Stratakis, C. A., & Muniyappa, R. (2021) · Endocrine · doi:10.1007/s12020-020-02576-y · Cited by 20
Self-citationIncreased β-Cell Responsivity Independent of Insulin Sensitivity in Healthy African American Adults
Armiyaw, L., Sarcone, C., Fosam, A. E., & Muniyappa, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa234 · Cited by 18
Self-citationFortin, E., Lundin, M., Mellbin, L., Norhammar, A., Näsman, P., Smetana, S., Sörensson, P., Ferrannini, E., Rydén, L., & Ferrannini, G. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01950-0 · Cited by 12
“In addition, both peripheral and hepatic insulin sensitivity are typically included in OGTT-derived surrogates [35].”
Background
Metadata
- Authors
- Muniyappa, R., Tella, S. H., Sortur, S., Mszar, R., Grewal, S., Abel, B. S., Auh, S., Chang, D. C., Krakoff, J., & Skarulis, M. C.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Muniyappa, Ranganath
- ORCID
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2018-09-25
- Volume
- 3
- Issue
- 1
- Pages
- 108-118
- ISSN
- 2472-1972 (ISSN-L)
- PMC
- PMC6299271
- OpenAlex
- W2894010512
- Semantic Scholar
- 73592d1b8f0ffc33b21b7140e43d3680adc40abb
- Cited by
- 16
- References
- 46
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 2
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- Locations
- Journal of the Endocrine Society (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin sensitivity, hepatic insulin resistance, skeletal muscle insulin sensitivity, surrogate indices, oral glucose tolerance test, hepatic glucose production, prediction accuracy, calibration models, glucose tolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.